Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (91-100 of 324) with videos related to

Pageof 33
Sort By:
Journal of the International AIDS Society|April 1, 2018
The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in IndiaAmy Zheng, Nagalingeswaran Kumarasamy, Mingshu Huang, et al.
The American Journal of Medicine|March 14, 2007
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIVNicole G Campos, Joshua A Salomon, Julie C Servoss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South AfricaIngrid V Bassett, Senica Chetty, Bingxia Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2018
High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian CohortAimalohi A Ahonkhai, Bolanle Banigbe, Juliet Adeola, et al.
BMC Infectious Diseases|October 2, 2015
High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in NigeriaAimalohi A Ahonkhai, Bolanle Banigbe, Juliet Adeola, et al.
AIDS Care|May 25, 2023
HIV-related stigma and psychological distress in a cohort of patients receiving antiretroviral therapy in NigeriaBentley Akoko, Susan Regan, Ifeoma Idigbe, et al.
HIV Clinical Trials|February 7, 2012
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug developmentBethany L Morris, Callie A Scott, Timothy J Wilkin, et al.
JAMA Network Open|January 21, 2026
Modeled Health and Economic Burden of Frailty and Falls Among Adults With HIVKaren C Smith, Cathryn Brown, Emily P Hyle, et al.
Open Forum Infectious Diseases|July 7, 2017
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South AfricaA David Paltiel, Amy Zheng, Milton C Weinstein, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 countBingxia Wang, Elena Losina, Ruth Stark, et al.
Pageof 33

Showing results (91-100 of 324) with videos related to

Sort By:
Pageof 33
Journal of the International AIDS Society|April 1, 2018
The cost-effectiveness and budgetary impact of a dolutegravir-based regimen as first-line treatment of HIV infection in IndiaAmy Zheng, Nagalingeswaran Kumarasamy, Mingshu Huang, et al.
The American Journal of Medicine|March 14, 2007
Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIVNicole G Campos, Joshua A Salomon, Julie C Servoss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2011
Loss to follow-up and mortality among HIV-infected people co-infected with TB at ART initiation in Durban, South AfricaIngrid V Bassett, Senica Chetty, Bingxia Wang, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 14, 2018
High Medication Possession Ratios Associated With Greater Risk of Virologic Failure Among Youth Compared With Adults in a Nigerian CohortAimalohi A Ahonkhai, Bolanle Banigbe, Juliet Adeola, et al.
BMC Infectious Diseases|October 2, 2015
High rates of unplanned interruptions from HIV care early after antiretroviral therapy initiation in NigeriaAimalohi A Ahonkhai, Bolanle Banigbe, Juliet Adeola, et al.
AIDS Care|May 25, 2023
HIV-related stigma and psychological distress in a cohort of patients receiving antiretroviral therapy in NigeriaBentley Akoko, Susan Regan, Ifeoma Idigbe, et al.
HIV Clinical Trials|February 7, 2012
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug developmentBethany L Morris, Callie A Scott, Timothy J Wilkin, et al.
JAMA Network Open|January 21, 2026
Modeled Health and Economic Burden of Frailty and Falls Among Adults With HIVKaren C Smith, Cathryn Brown, Emily P Hyle, et al.
Open Forum Infectious Diseases|July 7, 2017
Setting Performance Standards for a Cost-Effective Human Immunodeficiency Virus Cure Strategy in South AfricaA David Paltiel, Amy Zheng, Milton C Weinstein, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|July 27, 2011
Loss to follow-up in a community clinic in South Africa--roles of gender, pregnancy and CD4 countBingxia Wang, Elena Losina, Ruth Stark, et al.
Pageof 33